Company profile

Laboratorios Farmacéuticos Rovi, S.A.

small molecule and specialty biologics; injectable/prefilled-syringe CDMO

ROVI · Bolsa de Madrid (BME) · Madrid, Spain

Public Market Listing

ROVIBolsa de Madrid (BME)

Bolsa de Madrid (BME) primary exchange listing

Live quotes, historical charts, and market capitalization for Laboratorios Farmacéuticos Rovi, S.A. are available on Yahoo Finance.

View quote & market cap on Yahoo Finance ↗

External market data link · No third-party exchange redistribution

Assets

(2 total)
2Total Assets
1Approved
0Phase 3 / Filed
1Phase 1–2 / Early
1Diseases
Showing 2 of 2 assets
Target & Modality
Risperidone (Risvan)(Risvan)
Approved
Dopamine D2 and serotonin 5-HT2A receptors (antagonist)Small molecule
Schizophrenia
Risperidone (QUAR)
Phase 1
Dopamine D2 and serotonin 5-HT2 receptors (antagonist) · Dopamine D2 and serotonin 5-HT2A receptors (antagonist)Small molecule
Schizophrenia

Upcoming events

Research

Unlock the company readout calendar

Research includes estimated primary-completion dates, earnings report dates, and 'What to watch' trial analysis across this company’s pipeline.

Financial reports

Research

Unlock sourced financial history

Research includes quarterly, interim and annual revenue, R&D, cash and burn figures linked to the underlying company reports.

Educational data tool. Figures are sourced from company filings and press releases: see each row's filing link. Share price is delayed (~15min) and refreshed periodically, not a real-time feed.